Rhodin, K. E., Raman, V., Kanu, E., Eckhoff, A., Nussbaum, D. P., Lidsky, M. E., & Blazer, D. G. (2023). Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies. Ann Surg Oncol, 30(9), 5323–5326. https://doi.org/10.1245/s10434-023-13641-x

Rhodin, Kristen E., Vignesh Raman, Elishama Kanu, Austin Eckhoff, Daniel P. Nussbaum, Michael E. Lidsky, and Dan G. Blazer. “Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies.” Ann Surg Oncol 30, no. 9 (September 2023): 5323–26. https://doi.org/10.1245/s10434-023-13641-x.

Rhodin KE, Raman V, Kanu E, Eckhoff A, Nussbaum DP, Lidsky ME, et al. Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies. Ann Surg Oncol. 2023 Sep;30(9):5323–6.

Rhodin, Kristen E., et al. “Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies.” Ann Surg Oncol, vol. 30, no. 9, Sept. 2023, pp. 5323–26. Pubmed, doi:10.1245/s10434-023-13641-x.

Rhodin KE, Raman V, Kanu E, Eckhoff A, Nussbaum DP, Lidsky ME, Blazer DG. Trends and Disparities in Clinical Trial Enrollment as Part of First-Line Treatment for Upper Gastrointestinal and Hepatopancreatobiliary Malignancies. Ann Surg Oncol. 2023 Sep;30(9):5323–5326.